Literature DB >> 17689680

Stat1 acetylation inhibits inducible nitric oxide synthase expression in interferon-gamma-treated RAW264.7 murine macrophages.

Lucie Guo1, Hongtao Guo, Chengjiang Gao, Zhiyong Mi, William B Russell, Paul C Kuo.   

Abstract

BACKGROUND: We hypothesized that acetylation of the Stat1 regulates interferon-gamma (IFN-gamma) mediated macrophage expression of inducible nitric oxide synthase (iNOS).
METHODS: RAW 264.7 iNOS expression was induced with IFN-gamma. Deacetylase inhibitors trichostatin A (TSA) or valproic acid (VPA) were added. Stat1 and iNOS mRNA and protein were measured. Acetylated Stat1 was determined by immunoprecipitation. Chromatin immunoprecipitation assessed in vivo binding of Stat1 to the iNOS promoter.
RESULTS: IFN-gamma significantly increased nitrite, iNOS protein and iNOS mRNA, and iNOS promoter activation. (P < .01 vs control for nitrite, protein, and mRNA). TSA-mediated acetylation decreased these to levels that were not different from controls. IFN-gamma increased acetylated Stat1 by 5-fold (P < .02 vs control); TSA + IFN-gamma caused an additional 4-fold increase in acetylated Stat1 (P < .05 vs IFN alone). Stat1 binding to the iNOS promoter increased 8-fold with IFN-gamma (P < .01 vs control). In TSA + IFN-gamma, Stat1 binding was not different from controls. Although less potent than TSA, VPA also significantly decreased nitrite, iNOS protein, iNOS mRNA, Stat1 acetylation, and Stat1 binding.
CONCLUSIONS: Acetylation of Stat1 protein correlates with decreased Stat1 binding to the iNOS promoter with resultant inhibition of IFN-gamma-mediated iNOS expression. Acetylation of the Stat1 protein may downregulate iNOS expression in proinflammatory states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689680      PMCID: PMC2034510          DOI: 10.1016/j.surg.2007.02.016

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  22 in total

Review 1.  Acetylation: a regulatory modification to rival phosphorylation?

Authors:  T Kouzarides
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  p300-mediated acetylation of human transcriptional coactivator PC4 is inhibited by phosphorylation.

Authors:  B R Kumar; V Swaminathan; S Banerjee; T K Kundu
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

4.  Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.

Authors:  R W Ganster; B S Taylor; L Shao; D A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 5.  Nitric oxide and shock.

Authors:  R G Kilbourn; D L Traber; C Szabó
Journal:  Dis Mon       Date:  1997-05       Impact factor: 3.800

6.  Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model.

Authors:  M F Doursout; R G Kilbourn; C J Hartley; J E Chelly
Journal:  J Crit Care       Date:  2000-03       Impact factor: 3.425

7.  Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions.

Authors:  Raymond W Ganster; Zhong Guo; Lifang Shao; David A Geller
Journal:  J Interferon Cytokine Res       Date:  2005-11       Impact factor: 2.607

8.  Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters.

Authors:  S C Chu; J Marks-Konczalik; H P Wu; T C Banks; J Moss
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

9.  Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways.

Authors:  H Kleinert; T Wallerath; G Fritz; I Ihrig-Biedert; F Rodriguez-Pascual; D A Geller; U Förstermann
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

10.  Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.

Authors:  M I Darville; D L Eizirik
Journal:  Diabetologia       Date:  1998-09       Impact factor: 10.122

View more
  7 in total

1.  HDAC inhibitor-mediated beta-cell protection against cytokine-induced toxicity is STAT1 Tyr701 phosphorylation independent.

Authors:  Mattias S Dahllöf; Dan P Christensen; Mette Harving; Bridget K Wagner; Thomas Mandrup-Poulsen; Morten Lundh
Journal:  J Interferon Cytokine Res       Date:  2014-07-25       Impact factor: 2.607

2.  STAT1 signaling is not regulated by a phosphorylation-acetylation switch.

Authors:  Filipa Antunes; Andreas Marg; Uwe Vinkemeier
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

3.  Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway.

Authors:  Tao Gaojian; Qian Dingfei; Li Linwei; Wang Xiaowei; Zhou Zheng; Liu Wei; Zhu Tong; Ning Benxiang; Qian Yanning; Zhou Wei; Chen Jian
Journal:  Cell Death Discov       Date:  2020-10-06

4.  Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.

Authors:  Prerna Kumar; Venkateswara R Gogulamudi; Ramu Periasamy; Giri Raghavaraju; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-31

Review 5.  Regulation of STAT signaling by acetylation.

Authors:  Shougang Zhuang
Journal:  Cell Signal       Date:  2013-05-22       Impact factor: 4.315

6.  Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells.

Authors:  P Shou; Q Chen; J Jiang; C Xu; J Zhang; C Zheng; M Jiang; T Velletri; W Cao; Y Huang; Q Yang; X Han; L Zhang; L Wei; A B Rabson; Y E Chin; Y Wang; Y Shi
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

7.  HDAC8 Inhibition Reduces Lesional Iba-1+ Cell Infiltration after Spinal Cord Injury without Effects on Functional Recovery.

Authors:  Sven Hendrix; Selien Sanchez; Elissia Ventriglia; Stefanie Lemmens
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.